Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2024 Earnings Call Transcript February 27, 2025
Intellia Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.24, expectations were $-1.32.
Operator: Good morning, and welcome to Intellia Therapeutics’ Fourth Quarter and Full-Year 2024 Financial Results Conference Call. My name is Drew, and I will be your conference operator today. Following formal remarks, we will open the call up for a question-and-answer session. This conference...
